Literature DB >> 10950779

Prospective study of prognostic factors in community-acquired bacteremic pneumococcal disease in 5 countries.

M Kalin1, A Ortqvist, M Almela, E Aufwerber, R Dwyer, B Henriques, C Jorup, I Julander, T J Marrie, M A Mufson, R Riquelme, A Thalme, A Torres, M A Woodhead.   

Abstract

To define the influence of prognostic factors in patients with community-acquired pneumococcal bacteremia, a 2-year prospective study was performed in 5 centers in Canada, the United States, the United Kingdom, Spain, and Sweden. By multivariate analysis, the independent predictors of death among the 460 patients were age >65 years (odds ratio [OR], 2.2), living in a nursing home (OR, 2.8), presence of chronic pulmonary disease (OR, 2.5), high acute physiology score (OR for scores 9-14, 7.6; for scores 15-17, 22; and for scores >17, 41), and need for mechanical ventilation (OR, 4.4). Of patients with meningitis, 26% died. Of patients with pneumonia without meningitis, 19% of those with >/=2 lobes and 7% of those with only 1 lobe involved (P=.0016) died. The case-fatality rate differed significantly among the centers: 20% in the United States and Spain, 13% in the United Kingdom, 8% in Sweden, and 6% in Canada. Differences of disease severity and of frequencies and impact of underlying chronic conditions were factors of probable importance for different outcomes.

Entities:  

Mesh:

Year:  2000        PMID: 10950779     DOI: 10.1086/315760

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  42 in total

1.  Clinical presentation, processes and outcomes of care for patients with pneumococcal pneumonia.

Authors:  J A Brandenburg; T J Marrie; C M Coley; D E Singer; D S Obrosky; W N Kapoor; M J Fine
Journal:  J Gen Intern Med       Date:  2000-09       Impact factor: 5.128

Review 2.  Bacteraemic pneumococcal pneumonia: current therapeutic options.

Authors:  Charles Feldman; Ronald Anderson
Journal:  Drugs       Date:  2011-01-22       Impact factor: 9.546

3.  Invasive Streptococcus pneumoniae in France: antimicrobial resistance, serotype, and molecular epidemiology findings from a monthly national study in 2000 to 2002.

Authors:  Jean-Winoc Decousser; Patrick Pina; Florent Viguier; Franc Picot; Patrice Courvalin; Pierre Allouch
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

4.  Addition of a macrolide to a ss-lactam in bacteremic pneumococcal pneumonia.

Authors:  R Dwyer; A Ortqvist; E Aufwerber; B Henriques Normark; T J Marrie; M A Mufson; A Torres; M A Woodhead; M Alenius; M Kalin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-08       Impact factor: 3.267

5.  Comparison between pathogen directed antibiotic treatment and empirical broad spectrum antibiotic treatment in patients with community acquired pneumonia: a prospective randomised study.

Authors:  M M van der Eerden; F Vlaspolder; C S de Graaff; T Groot; W Bronsveld; H M Jansen; W G Boersma
Journal:  Thorax       Date:  2005-08       Impact factor: 9.139

6.  Clinical outcomes of bacteremic pneumococcal infections in an area with high resistance.

Authors:  P L Ho; T L Que; T K Ng; S S Chiu; R W H Yung; K W T Tsang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-05       Impact factor: 3.267

7.  The lack of Pneumococcal surface protein C (PspC) increases the susceptibility of Streptococcus pneumoniae to the killing by microglia.

Authors:  Samuele Peppoloni; Bruna Colombari; Rachele Neglia; Daniela Quaglino; Francesco Iannelli; Marco Rinaldo Oggioni; Gianni Pozzi; Elisabetta Blasi
Journal:  Med Microbiol Immunol       Date:  2005-05-21       Impact factor: 3.402

8.  Epidemiology of invasive pneumococcal disease and vaccine provision in a tertiary referral center.

Authors:  C Rock; C Sadlier; J Fitzgerald; M Kelleher; C Dowling; S Kelly; C Bergin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-03-24       Impact factor: 3.267

9.  The impact of pre-existing heart failure on pneumonia prognosis: population-based cohort study.

Authors:  Reimar W Thomsen; Nongyao Kasatpibal; Anders Riis; Mette Nørgaard; Henrik T Sørensen
Journal:  J Gen Intern Med       Date:  2008-06-24       Impact factor: 5.128

10.  Comparative in vitro activity of faropenem and 11 other antimicrobial agents against 250 invasive Streptococcus pneumoniae isolates from France.

Authors:  J W Decousser; P Pina; F Picot; P Y Allouch
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-08-27       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.